News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress
Photo taken from Jessica MacIntyre/LinkedIn
Jan 9, 2025, 17:18

Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress

Jessica MacIntyre, President of Oncology Nursing Society, shared a post by Oncology Nursing Society on LinkedIn, adding:

“Excited for this year’s monumental 50th Annual Oncology Nursing Society Congress. Make it the first thing you check off in 2025! Once you attend, you’ll want to come back every year! Don’t miss out-register today and be part of this unforgettable event!”

Quoting Oncology Nursing Society’s post:

“Celebrate yesterday and transform tomorrow at the largest conference dedicated to oncology nurses, ONS Congress. You don’t want to miss it! Register now.”

Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress

cancer Jessica MacIntyre OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 1, 2025, 13:02
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Oncolibrary
Jun 1, 2025, 12:40
Metacure Cohorts B2 Results: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
Oncolibrary
Jun 1, 2025, 12:03
EV-302 Updates at ASCO 2025: Enfortumab Vedotin Plus Pembrolizumab Doubles Complete Response Rate in Advanced Urothelial Carcinoma
Oncolibrary
Jun 1, 2025, 11:55
Tagitanlimab Boosts Chemotherapy in Nasopharyngeal Cancer: Phase 3 Results at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:51
FIRE-4 Study Results: Cetuximab Re-challenge in Metastatic RAS Wild-Type Colorectal Cancer
Oncolibrary
Jun 1, 2025, 11:45
Combining Darolutamide and Goserelin: A New Frontier in Fighting Salivary Gland Cancer at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:44
SURE-02 Phase 2 Trial Interim Results: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Promising Bladder Preservation in Muscle-Invasive Bladder Cancer
Blog
Jun 1, 2025, 11:42
Estela Rodriguez: Day 2 ASCO25 Agenda
Blog
Jun 1, 2025, 11:35
Mario Balsa: Breaking from ASCO 2025 - DESTINY-Gastric04 Trial
Blog
Jun 1, 2025, 11:33
Cristiane Bergerot: Genomic Insights from IMmotion010
Oncolibrary
Jun 1, 2025, 11:24
CheckMate 901 Trial Final Results at ASCO 2025: Nivolumab + Ipilimumab Shows Durable Responses in Cisplatin-Ineligible Metastatic Urothelial Carcinoma
Blog
Jun 1, 2025, 11:07
Armando Orlandi: ASCO25 Breast Cancer Update, Early Data from May 30th Session